• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMichael Pearson

Michael Pearson

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceFormer Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company
By Lucinda ShenJuly 13, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s Former CEO Will Stay on as an $83,000-a-Month Consultant
By Lucinda ShenMay 31, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceAckman Bids Farewell to Man Who Pushed for Disastrous Valeant Investment
By Laura LorenzettiMay 12, 2016
FinanceThis Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
By Laura LorenzettiMay 10, 2016
Fortune Global Forum 2015
LeadershipMeet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
By Bill GeorgeMay 10, 2016
Squawk Box - Season 20
FinanceBill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthValeant’s CEO Just Avoided Contempt Charges From the U.S. Senate
By ReutersApril 13, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant CEO Promises Company Won’t Go Bankrupt in Staff Memo
By Jen WiecznerMarch 18, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Valeant Shares Plummeted Again
By Laura LorenzettiMarch 17, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s Shares Are Having An Epically Bad Day
By Jen WiecznerMarch 15, 2016
Inside The 2016 Consumer Electronics Show
FinanceThese Stock Market-Battered Execs Just Became Ex-Billionaires
By Robert HackettJanuary 26, 2016
valeant ceo michael pearson
LeadershipValeant’s CEO Isn’t Sure When He’ll Return from Medical Leave
By ReutersJanuary 25, 2016
Janet Yellen Testifies Before House Financial Services Committee
FinanceEnd of Easy Money Brings Relief
By Alan MurrayDecember 17, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant accounting scandal: 4 critical questions that have been left unanswered
By Stephen GandelOctober 26, 2015
1
  • 1
1
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO commander warnsAn image of a popular article
By Jason MaFebruary 28, 2026
AI
The week the AI scare turned real and America realized maybe it isn't ready for what's comingAn image of a popular article
By Nick LichtenbergFebruary 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.